The present study assessed the ability of a rapid chemiluminescent DNA probe assay to detect bacterial growth in blood culture specimens before their detection by continuous-monitoring blood culture (CMBC) systems.
In cases of suspected neonatal sepsis, the early detection of positive blood cultures allows timely institution of appropriate antibiotics and aids in decisions regarding the duration of their administration. Conversely, the early confirmation of negative blood cultures is important in minimizing the unnecessary use of antibiotics, which is costly and not without potential morbidity. [1] [2] [3] For these reasons, there is great interest in new methodology that will confirm the presence or absence of bacterial growth within culture at the earliest possible time.
The latest generation of blood culture systems employs continuous reading devices, which alert laboratory personnel when bacterial growth is detected. This is in contrast to the prior generation of blood culture systems in which culture bottles were usually assessed only twice daily for bacterial growth. In addition, the newer systems are noninvasive, thereby minimizing the chance of specimen contamination. 4 Not only are traditional microbiologic detection systems being improved, but new technologies are being developed that may complement or replace traditional culture methods. One such advance is the improved use of DNA probes. 5 An existing DNA probe (AccuProbe; Gen-Probe, Inc., San Diego, CA) makes it possible to detect any species of bacteria in patient specimens by hybridizing with generic bacterial ribosomal RNA. 6 In a preliminary study of a pediatric population, we found this probe to exhibit 100% sensitivity in the detection of microorganisms when it was assayed on aliquots taken from patient blood cultures that had been allowed to incubate under routine conditions for 8 to 14 hours. 7 The present study compared the generic probe technology with continuous-monitoring blood culture (CMBC) systems in detecting bacterial growth within blood culture specimens from a newborn population. To this end, we used the DNA probe to analyze aliquots taken from blood culture bottles during early incubation (mean of 14 hours) and compared the sensitivity of detection with that of the CMBC systems.
MATERIALS AND METHODS

Patient Selection
The study received institutional review board approval and was performed at each of three institutions which are members of the National Institute of Child Health and Human Development Neonatal Research Network, which includes the Indiana University Medical Center (Indianapolis, IN), the Stanford University Medical Center (Palo Alto, CA), and the University of New Mexico Medical Center (Albuquerque, NM). Only blood cultures obtained from patients in neonatal intensive care units were analyzed.
Blood Culture Processing
Each of the three study sites utilized an automated "continuous monitoring" blood culture system-BACTEC 9240 (Becton Dickinson, Sparks, MD), BacT/Alert (Organon Teknika, Durham, NC), or ESP (Difco, Detroit, MI). The BACTEC system uses a fluorescent sensor for detection of microorganisms; the BacT/Alert system uses a colorimetric means of detecting microbial growth; and the ESP system measures pressure changes to detect both consumption and production of various gases by microorganisms. All three systems are noninvasive and rely on the detection of CO 2 as the primary indicator for the presence of actively metabolizing microorganisms. Each culture bottle is monitored every 10 minutes by the BACTEC and BacT/Alert systems and every 12 minutes by the ESP system. Each site used 20-ml pediatric blood culture bottles.
Upon receipt in the laboratory, blood cultures were placed on the study sites' respective instrument according to the manufacturer's instructions and incubated at 35°C. The time of initiation of incubation was recorded. The center using the BACTEC system inoculated both an aerobic and an anaerobic culture bottle; however, only the aerobic bottle was analyzed in this study. The other two centers do not routinely inoculate anaerobic bottles for this patient population.
Pellet Preparation
Aliquots (3 ml) were removed from the blood cultures between 8 and 37 hours (mean 14 hours) of incubation. The time at which any given pellet was obtained was governed by the workflow and available personnel within each laboratory and was restricted to those cultures that had been incubating under standard conditions between 8 and 48 hours. Collected aliquots were then processed into "pellets." Each 3-ml aliquot was divided equally and centrifuged for 2 seconds at 8000 to 10,000g to sediment the red cells. The supernatant was then transferred to a second tube and centrifuged for 1 minute at 8000 to 10,000g. The supernatant was then discarded leaving a concentrated pellet. The pellet was frozen at Ϫ70°C for future DNA probe analysis.
DNA Probe Procedure
This study utilized a "generic" all-bacterial single-stranded DNA probe (Gen-Probe, Inc., San Diego, CA) that detects ribosomal RNA of the target to form a DNA:RNA hybrid. All bacterial ribosomal RNA possesses a common shared domain that is detected by the generic DNA probe. Detection is via an acridinium ester label that is directly attached to the probe and gives a "burst of light" when cleaved by the highly alkaline detection reagents. This signal is measured as relative light units (RLUs) in a luminometer.
The frozen sample pellets were shipped on dry ice to one centralized laboratory (Indiana University) every 2 weeks where the probe assay was performed. The assays were performed by personnel blinded to the blood culture results. Each pellet was washed twice with 1 ml of a buffered wash solution and repelleted as previously described. Because red blood cells naturally chemiluminesce, this wash procedure was necessary to remove any red blood cells or cellular debris that might have remained after centrifugation and could have caused false-positive results. Next, 250 l of lysing reagent and 50 l of the washed pellet sample were placed in a 12-ϫ 75-mm reaction tube, vortexed, and placed in a heat block for 10 minutes at 95°C. 50 l of the resulting solution was removed from the reaction tube and added to a second 12-ϫ 75-mm reaction tube containing 50 l of probe reagent. This tube was then sealed, vortexed, and incubated for 30 minutes in water bath at 60°C. The tube was again removed from the water bath, and 300 l of selection reagent was added. The tubes were resealed, vortexed, and placed back in the water bath at 60°C for 10 minutes. After being removed from the water bath and allowed to cool to room temperature for 5 minutes, the tube was analyzed in a luminometer and RLUs were recorded. RLU values greater than 20,000 were considered positive.
Data Analysis
Culture data were collected at each study site and forwarded to the principal investigator at Indiana University. To adequately assess the sensitivity and specificity of this study, specimens were analyzed in a blinded fashion. The probe result was compared with the final blood culture result as provided by each participating center.
RESULTS
Of the 1788 neonatal blood cultures obtained during this study, 1700 were received and processed appropriately to allow comparisons between culture and probe. Of those 1700 cultures, 763 were analyzed using the BACTEC system, 610 using the BacT/Alert system, and 327 using the ESP blood culture system. One hundred thirty (7.6%) blood cultures yielded bacterial growth; 66 from BACTEC, 31 from BacT/ Alert, and 33 from ESP. Coagulase-negative staphylococci (CNS) accounted for 67% of the isolated organisms followed by Klebsiella species, Escherichia coli, and Enterococcus species ( Table 1) .
The mean time to detection of bacterial growth was 20.6 hours for the BACTEC system, 24.6 hours for the BacT/Alert, and 19.3 hours for the ESP system ( Table 2 ). The mean time of aliquot collection for the pellets yielding a corresponding positive blood culture was 14.7 hours for BACTEC, 14.9 hours for BacT/Alert, and 11.7 hours for ESP.
For those cultures that were detected as positive on a blood culture instrument in less than 12 hours, 85% were also positive by the probe. For those cultures that were detected as positive on a blood culture instrument between 12 and 24 hours, 40% were probe-positive. Of the cultures that were positive by a blood culture instrument be-tween 24 and 36 hours, only 19% were detected by the probe. Only 1 of the 10 cultures detected as positive by a blood culture instrument after 36 hours of incubation was detected by the probe. There were 19 probe-positive/culture negative.
The majority of CNS was not detected by a blood culture instrument until after 12 hours of incubation; however, of the five that were detected within 12 hours, four yielded a positive probe. Of CNS detected between 12 and 24 hours, only 18 of 59 (31%) yielded a positive probe. Of the 26 culture bottles detected by a blood culture instrument as positive for CNS after 24 hours, only 4 (16%) were probe-positive.
Of organisms other than CNS, 89% were detected by blood culture instrument within 24 hours. For those cultures that were positive within 12 hours, 90% were probe-positive. For those cultures detected between 12 and 24 hours, 58% were probe-positive (Table 2) .
Seventy-six percent of all positive blood cultures were detected on the blood culture instrument within the first 24 hours; 98% were detected within 48 hours.
Of the two blood cultures that were detected as positive after 48 hours, both grew CNS. One of these was detected at 51 hours and the other at 5 days, the latter being considered a contaminant. Therefore, 99% of clinically significant organisms was detected by CMBC systems within 48 hours.
DISCUSSION
It has been estimated that 5% to 10% of the newborn population in the United States undergoes an initial evaluation for sepsis. 8 This includes at least one blood culture and, in many instances, cultures of spinal fluid and urine. Because approximately 4 million infants are born in this country annually, the minimum estimates for newborn blood cultures would be 200 to 400,000. Additionally, approximately 80% of infants admitted to a newborn intensive care unit receive at least one blood culture, and many have numerous cultures drawn during their hospital course. Overall, a bacterial etiology will be detected in only 1% to 10% of newborn cases 9 ; however, in the population weighing Ͻ1500 gm, 25% will have one or more episodes of blood culture-proven sepsis. 10 Most infants being evaluated for sepsis will receive antibiotic therapy until cultures have remained negative for at least 72 hours. 11, 12 Earlier confirmation of negative blood cultures would allow prompt discontinuation of antibiotics in cases where their use is unwarranted. This would result in reductions in the cost of patient care, the morbidity associated with intravenous drug therapy, and the emergence of resistant strains of microorganisms.
The present study compared the ability of a DNA probe to detect the presence or absence of bacterial growth in blood culture specimens during early incubation with the ability of CMBC systems to document such growth. The probe exhibited a sensitivity of 44% and a specificity of 99%. Although the probe performed well in detecting bacterial growth in specimens that were identified early on as positive by the culture systems, its sensitivity falls dramatically in the detection of microorganisms that are positive by CMBC system detection after 12 hours. This is most likely a result of the fact that this probe hybridizes with bacterial ribosomal RNA, and a minimum amount of rRNA must be present for a positive result. If the organism is slow growing or the inoculum small, a sufficient amount of rRNA may not be present during early incubation when the majority of aliquots for probe assay were obtained. The sensitivity of the probe could be enhanced theoretically by amplification of the target using techniques such as polymerase chain reaction. However this could result in a loss of specificity due to false positives being generated by the amplification of microcontamination of specimens. 13 The ability of the probe to detect CNS during early incubation is much lower than its ability to detect other organisms. This is not surprising, because CNS bacteria grow slowly in culture as evidenced by the fact that only 5 of 90 specimens positive for CNS were detected in Ͻ12 hours by using a CMBC system. The critical mass of ribosomal RNA would not have been present at the time when the aliquot for probe assay was obtained. This consideration is of great importance because the coagulase-negative staphylococcus accounts for the majority of nosocomial infections in newborn intensive care populations. 10, 14, 15 Results of the current study are in stark contrast to results of our previous investigation. 7 However, in the previous study the population enlisted was that of the entire pediatric age group where the coagulase-negative staphylococcus is an infrequent pathogen. In addition, the blood inoculum put into culture from a newborn is significantly smaller than that obtained in older children. 16 Thus, in the older patient, a larger amount of blood obtained results in a larger inoculum and shorter incubation time required to obtain the critical mass of rRNA.
One unanticipated finding in this study was the fact that the CMBC systems used in these centers detected 99% of clinically significant microorganisms within 48 hours. In only two instances was an organism detected after 48 hours of incubation, and in both cases it was a coagulase-negative staphylococcus. One became positive at 51 hours and the other at 132 hours, the latter considered to be a contaminant. This rate of detection within 48 hours for neonatal cultures is improved over rates quoted for prior generations of blood culture systems in earlier studies: 91% by Rowley et al. 17 and 96% by Pichichero et al. 18 Because current recommendations suggest treating infants with suspected sepsis with antibiotics until cultures are negative for at least 3 days, 19, 20 our findings have significant clinical and economic importance.
In summary, this study has compared the ability of a polymicrobial DNA probe to detect the presence and absence of bacterial growth during early incubation with that of currently used CMBC systems. As used in this study the probe lacks sensitivity to offer any advantage over routine culture; however, it may prove useful in combination with amplification techniques such as polymerase chain reaction. Most importantly, results of our study indicate that CMBC systems are sufficiently sensitive for detecting bacterial growth within 48 hours and that clinical decisions regarding the need for continued antibiotic therapy can be made at 48 hours rather than 72 hours.
